Currently, Pacific Biosciences of California Inc [PACB] is trading at $1.29, up 4.03%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PACB shares have gain 7.50% over the last week, with a monthly amount glided 33.86%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pacific Biosciences of California Inc [NASDAQ: PACB] stock has seen the most recent analyst activity on November 11, 2024, when UBS downgraded its rating to a Neutral. On April 22, 2024, downgrade downgraded it’s rating to Neutral. Goldman downgraded its rating to a Neutral and decreased its price target to $2.50 on April 18, 2024. Stephens initiated its recommendation with a Overweight and recommended $11 as its price target on December 14, 2023. In a note dated December 13, 2023, Wolfe Research initiated an Peer Perform rating.
This stock has fluctuated between a low of $0.85 and a high of $2.72 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $1.5 within the next 12 months. Pacific Biosciences of California Inc [NASDAQ: PACB] shares were valued at $1.29 at the most recent close of the market. An investor can expect a potential return of 16.28% based on the average PACB price forecast.
Analyzing the PACB fundamentals
Trailing Twelve Months sales for Pacific Biosciences of California Inc [NASDAQ:PACB] were 152.36M which represents -4.27% decline. Gross Profit Margin for this corporation currently stands at 0.16% with Operating Profit Margin at -5.19%, Pretax Profit Margin comes in at -4.32%, and Net Profit Margin reading is -4.32%. To continue investigating profitability, this company’s Return on Assets is posted at -0.76, Equity is -1.7 and Total Capital is -1.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of7.63.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.2233 points at the first support level, and at 1.1567 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3333, and for the 2nd resistance point, it is at 1.3767.
Pacific Biosciences of California Inc [PACB] reported earnings per share of -$0.15 for its fiscal quarter that ended on 3/31/2025. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.19/share, meaning a difference of $0.04 and a surprise factor of 20.51%. By comparison, the stated earnings for the previous quarter ended on 12/31/2024 were -$0.2 per share as compared to estimates of -$0.17 per share, a difference of $-0.03 representing a surprise of -15.50%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Pacific Biosciences of California Inc [NASDAQ:PACB] is 6.68. Also, the Quick Ratio is 5.87, while the Cash Ratio stands at 0.88. Considering the valuation of this stock, the price to sales ratio is 2.54, the price to book ratio is 4.22.
Transactions by insiders
Recent insider trading involved Farmer Michele,, that happened on May 19 ’25 when 5195.0 shares were sold., HENRY CHRISTIAN O completed a deal on Mar 03 ’25 to sell 12497.0 shares. Meanwhile, Van Oene Mark sold 6486.0 shares on Mar 03 ’25.
